368 related articles for article (PubMed ID: 26318853)
1. NF-κB signaling in cancer stem cells: a promising therapeutic target?
Vazquez-Santillan K; Melendez-Zajgla J; Jimenez-Hernandez L; Martínez-Ruiz G; Maldonado V
Cell Oncol (Dordr); 2015 Oct; 38(5):327-39. PubMed ID: 26318853
[TBL] [Abstract][Full Text] [Related]
2. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
Wang D; Fu L; Sun H; Guo L; DuBois RN
Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
[TBL] [Abstract][Full Text] [Related]
3. Novel approaches to target NF-κB and other signaling pathways in cancer stem cells.
Ukaji T; Umezawa K
Adv Biol Regul; 2014 Sep; 56():108-15. PubMed ID: 25128192
[TBL] [Abstract][Full Text] [Related]
4. NF-kappaB as a potential molecular target for cancer therapy.
Lee CH; Jeon YT; Kim SH; Song YS
Biofactors; 2007; 29(1):19-35. PubMed ID: 17611291
[TBL] [Abstract][Full Text] [Related]
5. Lipopolysaccharide supports maintaining the stemness of CD133(+) hepatoma cells through activation of the NF-κB/HIF-1α pathway.
Lai FB; Liu WT; Jing YY; Yu GF; Han ZP; Yang X; Zeng JX; Zhang HJ; Shi RY; Li XY; Pan XR; Li R; Zhao QD; Wu MC; Zhang P; Liu JF; Wei LX
Cancer Lett; 2016 Aug; 378(2):131-41. PubMed ID: 27208741
[TBL] [Abstract][Full Text] [Related]
6. Curcumin effectively inhibits oncogenic NF-κB signaling and restrains stemness features in liver cancer.
Marquardt JU; Gomez-Quiroz L; Arreguin Camacho LO; Pinna F; Lee YH; Kitade M; Domínguez MP; Castven D; Breuhahn K; Conner EA; Galle PR; Andersen JB; Factor VM; Thorgeirsson SS
J Hepatol; 2015 Sep; 63(3):661-9. PubMed ID: 25937435
[TBL] [Abstract][Full Text] [Related]
7. Classic and Novel Signaling Pathways Involved in Cancer: Targeting the NF-κB and Syk Signaling Pathways.
Tang C; Zhu G
Curr Stem Cell Res Ther; 2019; 14(3):219-225. PubMed ID: 30033874
[TBL] [Abstract][Full Text] [Related]
8. 2-Methoxyestradiol inhibits the proliferation and migration and reduces the radioresistance of nasopharyngeal carcinoma CNE-2 stem cells via NF-κB/HIF-1 signaling pathway inactivation and EMT reversal.
Wu SL; Li YJ; Liao K; Shi L; Zhang N; Liu S; Hu YY; Li SL; Wang Y
Oncol Rep; 2017 Feb; 37(2):793-802. PubMed ID: 28000883
[TBL] [Abstract][Full Text] [Related]
9. The flavonoid apigenin reduces prostate cancer CD44(+) stem cell survival and migration through PI3K/Akt/NF-κB signaling.
Erdogan S; Doganlar O; Doganlar ZB; Serttas R; Turkekul K; Dibirdik I; Bilir A
Life Sci; 2016 Oct; 162():77-86. PubMed ID: 27569589
[TBL] [Abstract][Full Text] [Related]
10. The novel inhibitor BRM270 downregulates tumorigenesis by suppression of NF-κB signaling cascade in MDR-induced stem like cancer-initiating cells.
Mongre RK; Sodhi SS; Ghosh M; Kim JH; Kim N; Park YH; Kim SJ; Heo YJ; Sharma N; Jeong DK
Int J Oncol; 2015; 46(6):2573-85. PubMed ID: 25872586
[TBL] [Abstract][Full Text] [Related]
11. Deadly crosstalk: Notch signaling at the intersection of EMT and cancer stem cells.
Espinoza I; Miele L
Cancer Lett; 2013 Nov; 341(1):41-5. PubMed ID: 23973264
[TBL] [Abstract][Full Text] [Related]
12. NF-κB Signaling Pathway Inhibitors as Anticancer Drug Candidates.
de Castro Barbosa ML; da Conceicao RA; Fraga AGM; Camarinha BD; de Carvalho Silva GC; Lima AGF; Cardoso EA; de Oliveira Freitas Lione V
Anticancer Agents Med Chem; 2017; 17(4):483-490. PubMed ID: 27481554
[TBL] [Abstract][Full Text] [Related]
13. NF-κB in cancer therapy.
Li F; Zhang J; Arfuso F; Chinnathambi A; Zayed ME; Alharbi SA; Kumar AP; Ahn KS; Sethi G
Arch Toxicol; 2015 May; 89(5):711-31. PubMed ID: 25690730
[TBL] [Abstract][Full Text] [Related]
14. NF-kappaB and IKK as therapeutic targets in cancer.
Kim HJ; Hawke N; Baldwin AS
Cell Death Differ; 2006 May; 13(5):738-47. PubMed ID: 16485028
[TBL] [Abstract][Full Text] [Related]
15. Targeting Oncogenic Nuclear Factor Kappa B Signaling with Redox-Active Agents for Cancer Treatment.
Fouani L; Kovacevic Z; Richardson DR
Antioxid Redox Signal; 2019 Mar; 30(8):1096-1123. PubMed ID: 29161883
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic Effectiveness of Anticancer Phytochemicals on Cancer Stem Cells.
Oh J; Hlatky L; Jeong YS; Kim D
Toxins (Basel); 2016 Jun; 8(7):. PubMed ID: 27376325
[TBL] [Abstract][Full Text] [Related]
17. Regulation of apoptosis pathways in cancer stem cells.
Fulda S
Cancer Lett; 2013 Sep; 338(1):168-73. PubMed ID: 22429999
[TBL] [Abstract][Full Text] [Related]
18. Analysis of Several Pathways for Efficient Killing of Prostate Cancer Stem Cells: A Central Role of NF-κB RELA.
Witte KE; Pfitzenmaier J; Storm J; Lütkemeyer M; Wimmer C; Schulten W; Czaniera N; Geisler M; Förster C; Wilkens L; Knabbe C; Mertzlufft F; Kaltschmidt B; Am Esch JS; Kaltschmidt C
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445612
[TBL] [Abstract][Full Text] [Related]
19. Engineered nanoparticles as emerging gene/drug delivery systems targeting the nuclear factor-κB protein and related signaling pathways in cancer.
Eskandani R; Kazempour M; Farahzadi R; Sanaat Z; Eskandani M; Adibkia K; Vandghanooni S; Mokhtarzadeh A
Biomed Pharmacother; 2022 Dec; 156():113932. PubMed ID: 36411621
[TBL] [Abstract][Full Text] [Related]
20. Neuropilin-1 is expressed by breast cancer stem-like cells and is linked to NF-κB activation and tumor sphere formation.
Glinka Y; Mohammed N; Subramaniam V; Jothy S; Prud'homme GJ
Biochem Biophys Res Commun; 2012 Sep; 425(4):775-80. PubMed ID: 22885184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]